Claude Scheidegger
Impact in
Papers in
-
- HIV, Drug Use, Sexual Risk 2
- Hepatitis B Virus Studies 2
-
- Hepatitis C virus research 5
- Co-authors
- W. Zimmerli (3 shared papers)Werner Zimmerli (1 shared paper)Marius Kraenzlin (1 shared paper)Leticia Grize (1 shared paper)Christian Meier (1 shared paper)Christine Huber (1 shared paper)Peter Späth (1 shared paper)Andreas Schaffner (1 shared paper)
- Journals
- Swiss Medical Weekly (2 papers)Clinical Infectious Diseases (1 paper)AIDS (1 paper)Liver International (1 paper)European Journal of Clinical Microbiology & Infectious Diseases (1 paper)
- Partner nations
- SwitzerlandUnited StatesAustria
In The Last Decade
Claude Scheidegger
13 papers receiving 182 citations
Peers
Comparison fields: 5 of 66
- Toxicology 13
- Applied Microbiology and Biotechnology 7
- Hepatology 27
- Infectious Diseases 47
- Epidemiology 87
Countries citing papers authored by Claude Scheidegger
This map shows the geographic impact of Claude Scheidegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Scheidegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Scheidegger more than expected).
Fields of papers citing papers by Claude Scheidegger
This network shows the impact of papers produced by Claude Scheidegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Scheidegger. The network helps show where Claude Scheidegger may publish in the future.
Co-authors
The 25 scholars most cited alongside Claude Scheidegger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 74 | |
| 2 | 2016 | 38 | |
| 3 | 1996 | 26 | |
| 4 | 1991 | 17 | |
| 5 | 2021 | 10 | |
| 6 | 2021 | 9 | |
| 7 | 2010 | 6 | |
| 8 | 2020 | 5 | |
| 9 | 1997 | 2 | |
| 10 | 2018 | 2 | |
| 11 | 2021 | 1 | |
| 12 | 2014 | 1 | |
| 13 | 2018 | 1 |
About Claude Scheidegger
Claude Scheidegger is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Clinical Biochemistry and Public Health, Environmental and Occupational Health, having authored 13 papers that have together received 192 indexed citations. Recurring topics across this work include Hepatitis C virus research (5 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), HIV, Drug Use, Sexual Risk (2 papers), Hepatitis B Virus Studies (2 papers), Medical and Health Sciences Research (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Abdominal Trauma and Injuries (1 paper). The work is most often cited by research in Toxicology (13 citations), Applied Microbiology and Biotechnology (7 citations), Hepatology (27 citations), Infectious Diseases (47 citations) and Epidemiology (87 citations). Claude Scheidegger has collaborated with scholars based in Switzerland, United States and Austria. Frequent co-authors include W. Zimmerli, Werner Zimmerli, Marius Kraenzlin, Leticia Grize, Christian Meier, Christine Huber, Peter Späth, Andreas Schaffner, R. Scherz and Philip Bruggmann. Their work appears in journals such as Swiss Medical Weekly, Clinical Infectious Diseases, AIDS, Liver International and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.